Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Anna Ridolfo and Andrea Giacomelli.
Connection Strength

3.574
  1. Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy. BMC Infect Dis. 2018 Nov 12; 18(1):556.
    View in: PubMed
    Score: 0.795
  2. Clinical and genetic determinants of nevirapine plasma trough concentration. SAGE Open Med. 2018; 6:2050312118780861.
    View in: PubMed
    Score: 0.771
  3. Impact of gender on patients hospitalized for SARS-COV-2 infection: A prospective observational study. J Med Virol. 2021 07; 93(7):4597-4602.
    View in: PubMed
    Score: 0.234
  4. Low influenza vaccination coverage among hospitalized COVID-19 patients in Milan: A gap to be urgently filled. Eur J Intern Med. 2021 04; 86:100-101.
    View in: PubMed
    Score: 0.230
  5. Consumption of antibiotics at an Italian university hospital during the early months of the COVID-19 pandemic: Were all antibiotic prescriptions appropriate? Pharmacol Res. 2021 02; 164:105403.
    View in: PubMed
    Score: 0.230
  6. Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: A retrospective cohort study. J Med Virol. 2021 03; 93(3):1421-1427.
    View in: PubMed
    Score: 0.226
  7. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis. 2020 07 28; 71(15):889-890.
    View in: PubMed
    Score: 0.224
  8. 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study. Pharmacol Res. 2020 08; 158:104931.
    View in: PubMed
    Score: 0.221
  9. Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older. J Acquir Immune Defic Syndr. 2018 06 01; 78(2):193-201.
    View in: PubMed
    Score: 0.193
  10. Remdesivir in moderate to severe COVID-19: A matter of time? Pharmacol Res. 2021 08; 170:105711.
    View in: PubMed
    Score: 0.059
  11. Comment on: Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICU. J Antimicrob Chemother. 2021 05 12; 76(6):1650-1651.
    View in: PubMed
    Score: 0.059
  12. Unexpectedly High Frequency of Enterococcal Bloodstream Infections in Coronavirus Disease 2019 Patients Admitted to an Italian ICU: An Observational Study. Crit Care Med. 2021 01 01; 49(1):e31-e40.
    View in: PubMed
    Score: 0.058
  13. Clinical Features and Outcomes of Patients With Human Immunodeficiency Virus With COVID-19. Clin Infect Dis. 2020 11 19; 71(16):2276-2278.
    View in: PubMed
    Score: 0.057
  14. Drug-Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy. Drugs Aging. 2020 12; 37(12):925-933.
    View in: PubMed
    Score: 0.057
  15. Retinal findings in patients with COVID-19: Results from the SERPICO-19 study. EClinicalMedicine. 2020 Oct; 27:100550.
    View in: PubMed
    Score: 0.056
  16. Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status. Pharmacol Res. 2020 08; 158:104899.
    View in: PubMed
    Score: 0.055
  17. Evaluation of the concentrations of psychotropic drugs in HIV-infected versus HIV-negative patients: Potential implications for clinical practice. World J Biol Psychiatry. 2020 10; 21(8):651-657.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.